Actipulse Neuroscience (Winter 2022) - Startups.RIP

Back to all companies

Actipulse Neuroscience (Winter 2022) - Startups.RIP

Back to all companies

Actipulse Neuroscience

Winter 2022Active

Non-invasive brain stimulation is a widely-utilized, FDA cleared treatment used for patients diagnosed with depression, but is limited to a hospital setting due to the cost of the device, and complexity of treatment application. Our proprietary brain stimulation device allows patients to be treated directly from their home, with the same efficacy, and at a lower cost of treatment. Currently in FDA pivotal phase for Major Depressive Disorder, and Pilot phase for Alzheimer's and Parkinson diseases.

Founded

Unknown

Category

Mental Health Tech

YC Company Page www.actipulseneuroscience.com

No report yet — want us to research it?

This company has not been analyzed yet. Request a research report and we will email you when it is ready to view.

We will notify you as soon as the analysis is complete.